Houston Methodist Hospital (Medical Center) Neuromuscular Medicine (Neurology)

Fellowship · Houston, TX

Sponsored by Houston Methodist Hospital · Director Sheetal Shroff

Works by its people: 484
Authors: 10
First-author works: 88
Citations: 32,307

20112026

Topics

Amyotrophic Lateral Sclerosis Research 159
Myasthenia Gravis and Thymoma 27
Neuroinflammation and Neurodegeneration Mechanisms 22
Neuroscience and Neuropharmacology Research 20
Genetic Neurodegenerative Diseases 19
Ion channel regulation and function 18
Parkinson's Disease Mechanisms and Treatments 14
Alzheimer's disease research and treatments 12
Muscle Physiology and Disorders 7
Peripheral Neuropathies and Disorders 7
Mitochondrial Function and Pathology 6
Nuclear Receptors and Signaling 5

Most cited

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.
Nature medicine · 2026 · 14 citations · Sheetal Shroff
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
JAMA · 2025 · 22 citations · Stanley Appel, Sheetal Shroff
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
The Lancet. Neurology · 2023 · 50 citations · Ericka Greene
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA network open · 2025 · 19 citations · Stanley Appel, Sheetal Shroff
Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.
Alzheimer's research & therapy · 2025 · 18 citations · Stanley Appel
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
JAMA neurology · 2025 · 15 citations · Stanley Appel, Sheetal Shroff
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Acta neuropathologica communications · 2022 · 58 citations · Stanley Appel
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration.
Current opinion in neurology · 2021 · 62 citations · Stanley Appel

Topics

Amyotrophic Lateral Sclerosis Research 159

Myasthenia Gravis and Thymoma 27

Neuroinflammation and Neurodegeneration Mechanisms 22

Neuroscience and Neuropharmacology Research 20

Genetic Neurodegenerative Diseases 19

Ion channel regulation and function 18

Parkinson's Disease Mechanisms and Treatments 14

Alzheimer's disease research and treatments 12

Muscle Physiology and Disorders 7

Peripheral Neuropathies and Disorders 7

Mitochondrial Function and Pathology 6

Nuclear Receptors and Signaling 5

Most cited

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine · 2026 · 14 citations · Sheetal Shroff

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA · 2025 · 22 citations · Stanley Appel, Sheetal Shroff

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

The Lancet. Neurology · 2023 · 50 citations · Ericka Greene

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

JAMA network open · 2025 · 19 citations · Stanley Appel, Sheetal Shroff

Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.

Alzheimer's research & therapy · 2025 · 18 citations · Stanley Appel

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

JAMA neurology · 2025 · 15 citations · Stanley Appel, Sheetal Shroff

Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.

Acta neuropathologica communications · 2022 · 58 citations · Stanley Appel

Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration.

Current opinion in neurology · 2021 · 62 citations · Stanley Appel